Early-Onset Myopia Intervention Project
Key facts
- Who runs it
- Shanghai Eye Disease Prevention and Treatment Center
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 508 people, planned
- Started
- 1 Jun 2025
- Expected to end
- 31 May 2028
- Type of study
- Interventional, 4 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- 0.01% atropine eye drops
- 0.05% atropine eye drops
- Spectacle lenses with highly aspherical lenslets
- Record updated
- 16 September 2025
Who can take part
- Age
- 3 years to 6 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (11)Hide the full registry criteria
Who can take part
- Age 3-6 years, gender unrestricted
- Bilateral cycloplegic spherical equivalent (SE) ≤ +0.75 D, astigmatism ≤-2.5 D, anisometropia ≤2.5 D
- Best corrected visual acuity: ≥0.5 for ages 3-5, ≥0.7 for age 6
- Accept regular follow-up, written informed consent from guardians, verbal informed consent from children
- Possess normal thinking and language communication skills, and can actively cooperate to wear spectacles as required
Who cannot take part
- Current or previous use of other treatments for myopia intervention, such as pharmacological (atropine) and optical (orthokeratology lenses or DIMS spectacle lenses) approaches, interrupt use for at least 4 weeks
- Existence of strabismus or amblyopia or other binocular vision abnormalities, accommodation dysfunction, cataract and history of eye surgery
- Any ocular or systemic disease that may affect vision and refractive development (e.g., Keratoconus, Marfan syndrome, retinopathy of prematurity, etc.)
- Allergy or contraindication to cycloplegic drugs
- Epilepsy or other mental disorders unable to expressing consent
- Other conditions deemed unsuitable for participation by the researcher
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Myopia or pre-myopia
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The prevalence of myopia among children has been increasing year by year, which has become a globle public health issue. Studies have shown that defocusing lenses and atroping eyedrops can control the progression of myopia, but there is little evidence of its efficacy in myopia intervention of young pre-schoolers who will face a greater risk of progression to high myopia later in life. Therefore, this study aims to evaluate the effectiveness and safety of spectacle lenses with highly aspherical lenslets (Essilor's Stellest) , as well as 0.01% and 0.05% low concentration atropine eyedrops in myopia intervention among young children aged 3-6.
The 4 groups in the trial
- No InterventionNo study treatment, for comparison
No intervention for myopia control
- Spectacle Lenses with Highly Aspherical LensletsTreatment being tested
Wearing spectacle lenses with highly aspherical lenslets for myopia control
- 0.01% AtropineTreatment being tested
Nightly use of 0.01% atropine eyedrops for myopia control
Treatment: 0.01% atropine eye drops
- 0.05% AtropineTreatment being tested
Nightly use of 0.05% atropine eyedrops for myopia control
Treatment: 0.05% atropine eye drops
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Project on Myopia Surveillance and Intervention Services for Preschool Children in Shanghai
- Criteria questions
- Built from NCT07176949, who can take part
- Record updated
- 16 September 2025